(3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol

C35H49N7O3 — CID 177324421

IUPAC(3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol
SMILESC=C/C=C(\C(=C)O)c1cc2c(nn1)N(C(=C)C)CC1CN(CC3CCN(CCOc4cc(C(C=C)C(C)C)on4)CC3)CCN21
InChIInChI=1S/C35H49N7O3/c1-8-10-30(26(7)43)31-19-32-35(37-36-31)42(25(5)6)23-28-22-40(15-16-41(28)32)21-27-11-13-39(14-12-27)17-18-44-34-20-33(45-38-34)29(9-2)24(3)4/h8-10,19-20,24,27-29,43H,1-2,5,7,11-18,21-23H2,3-4,6H3/b30-10+
InChIKeyPBUCCYFPMUYUBV-WXMAUWIXSA-N
MW615.82 g/mol
LogP5.67
Rot. Bonds13

About (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol

(3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol (PubChem CID 177324421) has the molecular formula C35H49N7O3 and a molecular weight of 615.82 g/mol. Its IUPAC name is (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol.

Molecular Properties

Compound Name(3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol
PubChem CID177324421
Molecular FormulaC35H49N7O3
Molecular Weight615.82 g/mol
Exact Mass615.39
IUPAC Name(3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol
SMILESC=C/C=C(\C(=C)O)c1cc2c(nn1)N(C(=C)C)CC1CN(CC3CCN(CCOc4cc(C(C=C)C(C)C)on4)CC3)CCN21
InChIInChI=1S/C35H49N7O3/c1-8-10-30(26(7)43)31-19-32-35(37-36-31)42(25(5)6)23-28-22-40(15-16-41(28)32)21-27-11-13-39(14-12-27)17-18-44-34-20-33(45-38-34)29(9-2)24(3)4/h8-10,19-20,24,27-29,43H,1-2,5,7,11-18,21-23H2,3-4,6H3/b30-10+
InChIKeyPBUCCYFPMUYUBV-WXMAUWIXSA-N
XLogP5.67
TPSA94.23 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds13
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500615.82
LogP ≤ 55.67
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol?
The IUPAC name of (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol (CID 177324421) is (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol.
What is the SMILES notation for (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol?
The canonical SMILES for (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol is C=C/C=C(\C(=C)O)c1cc2c(nn1)N(C(=C)C)CC1CN(CC3CCN(CCOc4cc(C(C=C)C(C)C)on4)CC3)CCN21.
What is the InChIKey of (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol?
The InChIKey is PBUCCYFPMUYUBV-WXMAUWIXSA-N. The full InChI is InChI=1S/C35H49N7O3/c1-8-10-30(26(7)43)31-19-32-35(37-36-31)42(25(5)6)23-28-22-40(15-16-41(28)32)21-27-11-13-39(14-12-27)17-18-44-34-20-33(45-38-34)29(9-2)24(3)4/h8-10,19-20,24,27-29,43H,1-2,5,7,11-18,21-23H2,3-4,6H3/b30-10+.
What are the key properties of (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol?
(3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol has a molecular weight of 615.82 g/mol, XLogP of 5.67, 13 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (3Z)-3-[12-[[1-[2-[[5-(4-methylpent-1-en-3-yl)-1,2-oxazol-3-yl]oxy]ethyl]piperidin-4-yl]methyl]-8-prop-1-en-2-yl-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl]hexa-1,3,5-trien-2-ol is sourced from PubChem (CID 177324421), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).